1931 ⎘
Rearing or breeding animals, not otherwise provided for; New breeds of animals New breeds of vertebrates
Sub-classes:GENE INTRODUCTION METHOD, GENE THERAPY METHOD, AND TISSUE REGENERATION METHOD
#2ZEBRAFISH ANIMAL MODEL FOR INFLAMMATORY DISEASES AND METHOD FOR SCREEING ANTI-INFLAMMATORY AGENTS USING SAME
#3METHOD AND COMPOSITIONS FOR TREATING AND PROTECTING AGAINST PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME VIRUS
#4TRANSGENIC NON-HUMAN ANIMALS PRODUCING MODIFIED HEAVY CHAIN-ONLY ANTIBODIES
#5METHOD FOR PRODUCING NONHUMAN PRIMATE ANIMAL MODEL OF CEREBRAL INFARCTION AND PHARMACEUTICAL COMPOSITION FOR TREATMENT OF CEREBRAL INFARCTION
#6COMPOSITION FOR PREVENTION OR TREATMENT OF INTRACTABLE EPILEPSY COMPRISING mTOR INHIBITOR
#7METHOD FOR CONSTRUCTING AN ANIMAL MODEL OF OPEN-ANGLE GLAUCOMA
#8METHOD FOR TETRAPLOID INDUCTION IN FISH
#9FEED COMPOSITION FOR CONSTRUCTION OF STEATOHEPATITIS ANIMAL MODEL
#10METHODS OF CULTURING TUMOR INFILTRATING LYMPHOCYTES
#11COMPOSITION
#12HYBRID MICROBEADS WITH BIODEGRADABLE SURFACE AND HETEROGENEOUS SIZE DISTRIBUTION, AND COMPOSITIONS AND METHODS THEREOF
#13BLOCK COPOLYMERS
#14BILIARY ATRESIA MODEL
#15Methods and Compositions for RNA-Directed Target DNA Modification and For RNA-Directed Modulation of Transcription
#16Methods and Compositions for RNA-Directed Target DNA Modification and for RNA-Directed Modulation of Transcription
#17Transplant Fish Production Method, Transplant Fish, Hybrid Fish Species Production Method, and Hybrid Fish Species
#18COMMENSAL FUNGUS AND USES THEREOF
#19DRUG FOR TREATING AFTEREFFECTS OF NOVEL CORONAVIRUS INFECTION
#20Humanized M-CSF Mice
#21COMPOUND AND USE THEREOF IN PREPARATION OF MEDICAMENT FOR TREATING ALZHEIMER'S DISEASE
#22MAP44 POLYPEPTIDES AND CONSTRUCTS BASED ON NATURAL ANTIBODIES AND USES THEREOF
#23ANTHELMINTIC LABORATORY ANIMAL MODEL FOR HEARTWORM
#24ANIMAL MODEL OF CD19 CHIMERIC ANTIGEN RECEPTOR (CAR)-T CELL THERAPY FOR LEUKEMIA COMPLICATED BY CYTOKINE RELEASE SYNDROME (CRS), AND PREPARATION METHOD AND USE THEREOF
#25Methods and Compositions for RNA-Directed Target DNA Modification and For RNA-Directed Modulation of Transcription
#26EMBRYONIC CELL CULTURES AND METHODS OF USING THE SAME
#27METHODS AND COMPOSITIONS FOR TREATING AND PROTECTING AGAINST PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME VIRUS
#28BLOCK COPOLYMERS
#29METHOD FOR DIAGNOSIS AND TREATMENT OF AUTISM SPECTRUM DISORDER ON BASIS OF ACTIVITY REGULATION MECHANISM OF DORMANT NEURAL STEM CELL
#30Use Of Citicoline In Regulating Respiratory Chain Function Related Protein Level And Preparing Drug For Preventing And Treating Respiratory Chain Dysfunction
#31ANTIBODY PRODUCING NON-HUMAN ANIMALS
#32ANTIBODY PRODUCING NON-HUMAN ANIMALS
#33Recombinant constructs and transgenic fluorescent ornamental fish therefrom
#34METHOD FOR DIAGNOSIS OF NEURODEGENERATIVE DISEASES BY USING HPMA
#35CAS-READY MOUSE EMBRYONIC STEM CELLS AND MICE AND USES THEREOF
#36IN VITRO METHODS OF DIFFERENTIATING STEM CELLS INTO NEURONS AND NEURONS GENERATED USING THE SAME
#37ANTIBODY PRODUCING NON-HUMAN ANIMALS
#38A NON-HUMAN ANIMAL MAMMALIAN MODEL OF CHRONIC GLAUCOMA
#39TRANSGENIC MOUSE MODELS SUPPORTING HUMAN INNATE IMMUNE FUNCTION
#40NOVEL METHOD FOR PREPARING ANIMAL MODEL OF CEREBROVASCULAR DISEASE AND METHOD FOR PRODUCING ANIMAL HAVING SMALL INDIVIDUAL DIFFERENCE IN SUSCEPTIBILITY TO CEREBROVASCULAR DISEASE ONSET BY USING ANIMAL MODEL FOR CEREBROVASCULAR DISEASE PREPARED THEREBY
#41AGE-RELATED HEARING LOSS ANIMAL MODEL AND CONSTRUCTION METHOD THEREFOR
#42METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
#43METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA DIRECTED MODULATION OF TRANSCRIPTION
#44PRETREATMENT DRUG FOR T CELL INFUSION THERAPY FOR IMMUNE-CHECKPOINT INHIBITOR-RESISTANT TUMOR
#45TREATMENT OF EXCESSIVE NEOVASCULARIZATION
#46SYSTEM FOR DETECTING EXTRACELLULAR PURINERGIC RECEPTOR LIGAND, AND NON-HUMAN ANIMAL HAVING THE SYSTEM INTRODUCED THEREINTO
#47ANIMAL MODEL FOR NEURODEGENERATIVE DISORDERS
#48IL-15 HUMANIZED MOUSE MODEL AND USE THEREOF
#49METHOD FOR SCREENING THERAPEUTIC TARGET OF ACUTE GASTROINTESTINAL SYNDROME AND USE OF TIGAR TARGET IN PREPARATION OF MEDICINE FOR TREATING RADIATION-INDUCED GASTROINTESTINAL SYNDROME
#50Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#51Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#52Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#53Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#54GENETIC MODIFICATION NON-HUMAN ORGANISM, EGG CELLS, FERTILIZED EGGS, AND METHOD FOR MODIFYING TARGET GENES
#55METHOD OF PREPARING MOUSE MODEL OF HERPES
#56HEMOPHILIA B RAT MODEL
#57METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
#58METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
#59METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
#60METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
#61METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
#62Mouse model of alcohol-induced liver cancer
#63METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
#64Method for Producing Virus-Infected Cell Line and Animal Model
#65METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
#66ANTHELMINTIC LABORATORY ANIMAL MODEL FOR HEARTWORM
#67Combination of antisense RNA sequences and use in the production of tilapia with degenerated sexual organs
#68Sulfated-Oxysterol and Oxysterol Sulfation by Hydroxysterol Sulfotransferase Promote Lipid Homeostasis and Liver Tissue Regeneration
#69Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#70Adeno-associated virus antibodies, fragments thereof and encoding polynucleotides
#71Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#72METHOD FOR DEVELOPING ORGAN THAT LACKS SPECIFIC FUNCTIONAL CELL
#73TRANSPLANT FISH PRODUCTION METHOD, TRANSPLANT FISH, HYBRID FISH SPECIES PRODUCTION METHOD, AND HYBRID FISH SPECIES
#74Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#75L-serine compositions, methods and uses for treating neurodegenerative diseases and disorders
#76PATIENT-DERIVED AMYLOID XENOGRAFT NON-HUMAN ANIMAL MODEL
#77METHOD FOR CONSTRUCTING LUNG CANCER ANIMAL MODEL
#78Cas-ready mouse embryonic stem cells and mice and uses thereof
#79Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#80Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#81ADENO-ASSOCIATED VIRUS ANTIBODIES AND FRAGMENTS THEREOF
#82NON-CANONICAL SWI/SNF COMPLEX AND USES THEREOF
#83Composition for modifying target gene
#84BOS TAURUS CELL TYPE 'HO840003210132823'
#85Rat model of IgA nephropathy induced with a multimeric recombinant IgA fragment
#86Non-human animal having human IL-34 and use Thereof
#87Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#88ATOPIC DERMATITIS MODEL NON-HUMAN ANIMAL AND USE THEREOF
#89Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#90Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#91METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
#92COMPOSITIONS AND METHODS FOR TREATING A TUMOR SUPPRESSOR DEFICIENT CANCER
#93A METHOD OF GENERATING STERILE AND MONOSEX PROGENY
#94GRAVES' OPHTHALMOPATHY PHENOTYPE ANIMAL MODEL, CONSTRUCTION METHOD THEREFOR, AND METHOD FOR SCREENING THERAPEUTIC MATERIAL FOR GRAVES' OPHTHALMOPATHY
#95Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#96Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#97MAP44 POLYPEPTIDES AND CONSTRUCTS BASED ON NATURAL ANTIBODIES AND USES THEREOF
#98Single nucleotide polymorphisms and feeding efficiency in cattle
#99NON-HUMAN ANIMALS EXHIBITING DEGENERATIVE SYMPTOM ATTRIBUTED TO PROTEIN AGGREGATION
#100METHOD FOR PRODUCING FUSION PROTEIN, NUCLEIC ACID, CELL, AND ANIMAL
#101Methods and compositions for treating and protecting against porcine reproductive and respiratory syndrome virus
#102COMPOSITION FOR PREVENTION OR TREATMENT OF INTRACTABLE EPILEPSY COMPRISING mTOR INHIBITOR
#103Embryonic cell cultures and methods of using the same
#104COMPOSITIONS AND METHODS FOR SOMATIC CELL REPROGRAMMING AND MODULATING IMPRINTING
#105L-serine compositions, methods and uses for treating neurodegenerative diseases and disorders
#106HUMAN GENE CORRECTION
#107Non-Human Animal Model of Non-Alcoholic Fatty Liver Disease
#108strain inducing inflammation in liver
#109strain inducing inflammation in liver
#110vaccine
#111Humanized M-CSF mice
#112Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#113Anti-polyethylene glycol (PEG) antibody mouse model for rigorous assessment of PEG-based therapies
#114Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#115Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#116Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#117Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#118Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#119Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#120Control and Characterization of Psychotic States
#121Transgenic animals and methods of use
#122Block copolymers
#123METHOD FOR CHANGING CONDITION OF EYELID OF HAIRLESS ANIMAL
#124ADIPONECTIN-EXPRESSING REGULATORY T-CELL PRECURSORS, COMPOSITION AND METHODS THEREOF
#125variety ‘JE840003146074527’ and methods of use therof
#126GENETIC MARKERS AND USES THEREFOR
#127METHOD FOR ESTABLISHING ULCERATIVE COLITIS ANIMAL MODEL AND USE OF SAID MODEL
#128Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#129Genetically modified non-human animals and methods relating to complement dependent cytotoxicity
#130Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#131Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#132Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#133METHOD FOR HIGH PRODUCTION OF PROTEIN USING MAMMALIAN ARTIFICIAL CHROMOSOME VECTOR
#134METHOD FOR OBTAINING RETINAL DEGENERATION (rd) MODEL MOUSE HAVING LOW RISK OF CAUSING RETINAL DETACHMENT
#135METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
#136Recombinant constructs and transgenic fluorescent ornamental fish therefrom
#137METHODS FOR THE PRODUCTION OF STERILE FISH AND OTHER EGG-PRODUCING AQUATIC ANIMALS AND COMPOUNDS FOR USE IN THE METHODS
#138In vitro methods of differentiating stem cells into neurons and neurons generated using the same
#139METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
#140METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
#141METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
#142variety ‘HO840003150607238’ and methods of use thereof
#143Modulating biomarkers to increase tumor immunity and improve the efficacy of cancer immunotherapy
#144Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#145Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#146Method of producing a novel animal model for tauopathies
#147METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
#148METHODS OF MOUSE CLINICAL TRIAL
#149METHOD FOR INDUCING DIFFERENTIATION OF PLURIPOTENT STEM CELLS INTO GERMLINE STEM CELL-LIKE CELLS
#150INHIBITORS OF DIHYDROOROTATE DEHYDROGENASE
#151Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#152METHODS AND COMPOSITIONS TO INCREASE HUMAN SOMATIC CELL NUCLEAR TRANSFER (SCNT) EFFICIENCY BY REMOVING HISTONE H3-LYSINE TRIMETHYLATION, AND DERIVATION OF HUMAN NT-ESC
#153Method for developing organ that lacks specific functional cell
#154INFORMATION PROVIDING METHOD FOR DIAGNOSING PARKINSONS DISEASE
#155Recombinant HIV compositions and uses thereof in animal models
#156Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#157METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
#158Method for creating an animal model having traumatic optical nerve injury
#159Method for producing disease modeling non-human animal, disease modeling non-human animal, and method for screening drug and method for determining risk of disease using the same
#160GENOME EDITING METHOD
#161ANIMAL MODEL SYSTEM AND USES THEREOF
#162ENGINEERING OF HUMANIZED CAR T-CELL AND PLATELETS BY GENETIC COMPLEMENTATION
#163Cell and utilization thereof
#164Sulfated-Oxysterol and Oxysterol Sulfation by Hydroxysterol Sulfotransferase Promote Lipid Homeostasis and Liver Tissue Regeneration
#165MOUSE MODEL OF RETINAL DEGENERATION
#166Nucleic acid constructs and methods of using the same
#167Animal wound model and methods of use
#168Development of YY male fish broodstocks in a single generation
#169Animal models of corneal ectatic diseases, methods of producing, and methods of use thereof
#170KLEBSIELLA PNEUMONIAE STRAIN THAT INDUCES INFLAMMATION IN THE LIVER
#171Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#172COMPOSITION
#173A NON-HUMAN ANIMAL MODEL OF NEURODEGENERATIVE DISORDERS
#174Lactoferrin/albumin fusion protein and production method therefor
#175Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#176Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#177Kidney production method
#178Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#179Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#180Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#181Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#182Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#183Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#184Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#185Human antibody-producing non-human animal and method for preparing human antibodies using same
#186Method for screening antibody using patient-derived tumor spheroids
#187TRANSGENIC NON-HUMAN ANIMALS PRODUCING MODIFIED HEAVY CHAIN-ONLY ANTIBODIES
#188Animal model of Angelman Syndrome
#189Anti-aging transgenic Caenorhabditis elegans
#190Use of C1q/TNF-related protein-1 (CTRP1) to treat fatty liver disease
#191Atopic dermatitis model non-human animal and use thereof
#192Method for producing acoustic trauma deafness model animal, and acoustic trauma deafness model animal produced by the same
#193Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#194METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
#195METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
#196METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
#197METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
#198Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#199Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#200Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#201Methods and compositions or RNA-directed target DNA modification and for RNA-directed modulation of transcription
#202METHODS FOR INCREASING THE RATE OF GENETIC PROGRESS AND GENERATING INBRED LINES IN NON-HUMAN MAMMALS USING GAMETES DERIVED FROM EMBRYOS
#203Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#204Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#205Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#206Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#207Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#208Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#209Method for producing animal model of preterm birth and animal model of preterm birth produced by the method
#210Hybrid dairy cattle and systems for maximizing hybrid advantage
#211Hybrid dairy cattle and systems for maximizing hybrid advantage
#212Method of producing renal cells from differentiated cells
#213MOUSE MODEL OF RETINAL DEGENERATION
#214METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
#215Animal marking and inoculation
#216Tissue selective transgene expression
#217Tissue selective transgene expression
#218Transgenic pig which simultaneously expresses HO-1 gene and TNFR1-Fc gene, and comprises knocked-out GGTA1 gene, and use thereof
#219Human ARCAP transgenic mouse
#220METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
#221Compositions and methods for enhanced genome editing
#222METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
#223METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
#224METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
#225Animal models for nonalcoholic fatty liver disease
#226TREATMENT OF EXCESSIVE NEOVASCULARIZATION
#227INTERCELLULAR LABELING OF LIGAND-RECEPTOR INTERACTIONS
#228Method for producing YY super-male and XY physiological female common carps
#229Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#230Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#231Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#232A MOUSE MODEL OF NONALCOHOLIC STEATOHEPATITIS AND USES THEREOF
#233Methods of agent delivery into eggs and embryos of egg-producing aquatic animals for drug screening, agent toxicity assay and production of infertile fish
#234Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#235Non-human primate model of age-related macular degeneration and method for producing same
#236Thyroid stimulating hormone receptor peptides and uses thereof
#237METHOD FOR CHANGING CONDITION OF EYELID OF HAIRLESS ANIMAL
#238Block copolymers
#239BIRDS, METHOD FOR PRODUCING BIRDS, AND BIRD EGGS
#240Method for injectable delivery of a therapeutic agent into a fish embryo
#241Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#242Genetically modified non-human animals and methods relating to complement dependent cytotoxicity
#243Method for producing blood chimeric animal
#244MOUSE MODEL OF RETINAL DEGENERATION
#245Cell having ability to form stratified epithelial tissue, and method for producing same
#246ANTIBODY PRODUCING NON-HUMAN ANIMALS
#247ANTIBODY PRODUCING NON-HUMAN ANIMALS
#248Antibody producing non-human animals
#249ANTIBODY PRODUCING NON-HUMAN ANIMALS
#250Antibody producing non-human animals
#251Antibody producing non-human animals
#252Isolated adipose-derived mesenchymal stem cells treated with angelica extract or butylidenephthalide, and wherein the cells have an increased mitochondrial membrane potential and a decreased level of IL-8, and methods for treating parkinson's disease
#253Method for producing non-human large mammal or fish each capable of producing gamete originated from different individual
#254Feedstuffs for aquaculture comprising stearidonic acid
#255Disease model pig exhibiting stable phenotype, and production method thereof
#256Recombinant constructs and transgenic fluorescent ornamental fish therefrom
#257TRANSPLANT FISH PRODUCTION METHOD, TRANSPLANT FISH, HYBRID FISH SPECIES PRODUCTION METHOD, AND HYBRID FISH SPECIES
#258L-serine compositions, methods and uses for treating neurodegenerative diseases and disorders
#259Gene knockout method
#260Single nucleotide polymorphisms associated with bull fertility
#261FAS AND DRs ARE NOVEL MOLECULAR TARGETS OF SENESCENT CELLS
#262In vivo methods for identifying cancer-associated immunotherapy targets
#263ANIMAL MODEL FOR DRY EYE AND METHODS OF USE OF SUCH ANIMALS
#264Method for identifying wuzhishan miniature pig inbred line by using 145 SNPs
#265RECOMBINANT HBV CCCDNA, THE METHOD TO GENERATE THEREOF AND THE USE THEREOF
#266Method for reestablishment of pluripotent stem cells
#267HIGH EFFICIENCY, HIGH THROUGHPUT GENERATION OF GENETICALLY MODIFIED MAMMALS BY ELECTROPORATION
#268Humanized M-CSF mice
#269ANIMAL MODEL OF NEURONAL INJURY
#270Pharmaceutical composition for treating bone diseases which comprises protein comprising Frizzled 1, Frizzled 2 or Frizzled 7 extracellular cysteine-rich domain
#271Method for knock-in of DNA into target region of mammalian genome, and cell
#272Knockout mouse, method for screening substance for suppressing mesial temporal lobe epilepsy, and method for selecting technique for suppressing mesial temporal lobe epilepsy
#273Inflammation reporter system
#274Animal models of corneal angiogenesis and corneal ectatic diseases, methods of producing, and methods of use thereof
#275TGFß SIGNALING INDEPENDENT NAÏVE INDUCED PLURIPOTENT STEM CELLS, METHODS OF MAKING AND USE
#276Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#277Calcium reporter gene
#278Breeding method for obtaining heterosis in lined seahorses
#279Unilateral spinal cord compression
#280MOUSE MODEL OF RETINAL DEGENERATION
#281Variant angola marburg virus
#282Method and culture medium for preparing mammalian ovum or embryo in which zona pellucida has been thinned or eliminated, and method for fertilization using mammalian ovum prepared by same method
#283Recombinant constructs and transgenic fluorescent ornamental fish therefrom
#284Transgenic non-human mammal that expresses human MMP2
#285Animal models for evaluating pharmaceutical compounds
#286Genetic markers and uses therefor
#287Method for producing embryos by in vitro culture, and method, apparatus, and system for selecting embryos
#288MOUSE MODEL OF RETINAL DEGENERATION
#289Mouse model for engraftment potential
#290Block copolymers
#291Method for regenerating hair follicles using CD36-expressing dermal sheath cells
#292Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#293Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#294Intercellular labeling of ligand-receptor interactions
#295MODEL OF ALZHEIMER'S DISEASE
#296Methods of identifying compounds for the treatment of fibrosis by using S1PR5
#297Blastoid, cell line based artificial blastocyst
#298ANIMAL MODEL FOR EVALUATING PERFORMANCE OF HEMOSTATIC AGENT FOR INDUCING HEMORRHAGE IN COMMON CAROTID ARTERY OR SUPERIOR SAGITTAL SINUS, AND USE THEREOF
#299Sulfated-oxysterol and oxysterol sulfation by hydroxysterol sulfotransferase promote lipid homeostasis and liver proliferation
#300Fibrotic non-human animal, and use thereof